TLRY logo

TLRYTilray Brands Inc

$5.01
$0.03
(0.60%)
Today
Closed $5.01
$0.005
(0.10%)
After Hours
Updated: 07:58 PM EDT
EarningsJul 28
Mkt Cap$595.63M
Vol3.9M
News
all
press releases
This US Cannabis Giant Is Launching Its First Premium Offering In Germany – Why It Matters?
Tilray’s ARX brand will be launched at the world's largest cannabis expo and festival, Mary Jane Berlin 2026, which kicks off in two days.
Stocktwits
News Placeholder
More News
News Placeholder
S&P 500, Dow, Nasdaq Futures Decline As US Launches Fresh ‘Self-Defense Strikes’ On Iran: SMCI, TLRY, DKNG, CBRL In Focus
The U.S. launched fresh strikes on Iran late Tuesday in retaliation for the downing of an American combat helicopter near the Strait of Hormuz.
Stocktwits
News Placeholder
TLRY Stock Extends Green Run: Tilray Funds Lyphe Buyout And Debt Reduction With 1.6M New Shares
Cannabis stocks continue to benefit from Schedule III optimism, with investors now watching a June 29 hearing on broader marijuana rescheduling.
Stocktwits
News Placeholder
MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?
The cannabis ETF has surged 104% over the past year, outperforming both the North American Marijuana Index and the S&P 500.
Stocktwits
News Placeholder
Tilray Brands, Inc. (TLRY) Exceeds Market Returns: Some Facts to Consider
Tilray Brands, Inc. (TLRY) closed at $5.03 in the latest trading session, marking a +1.82% move from the prior day.
Zacks
News Placeholder
TLRY Stock Back Into The Limelight – A Look At The Key Developments That Sparked Investor Optimism
Tilray stock was in focus after a recent government effort to reclassify Hemp and the upcoming DEA hearing about marijuana.
Stocktwits
News Placeholder
Tilray Brands, Inc. (TLRY) Stock Slides as Market Rises: Facts to Know Before You Trade
The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $5.38, representing a -2% change from its previous close.
Zacks
News Placeholder
Curaleaf Prepares for US Exchange Uplisting: Time to Invest?
CURLF's reverse stock split and Delaware domestication plan signal preparation for a potential U.S. uplisting as revenue and international growth improve.
Zacks
News Placeholder
Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock?
JAZZ gains unique cannabis exposure through Epidiolex as strong sales growth and patent protection boost long-term visibility.
Zacks
News Placeholder
1 Wall Street Analyst Thinks Tilray Will Soar Nearly 75%. Is It a Buy Now?
Key PointsLast month, Roth Capital's William Kirk upgraded Tilray Brands shares from "neutral" to "buy," raising his price target to $10 per share...
Nasdaq News: Markets
<
1
2
...
>

Advertisement|Remove ads.